AMPLIFICATION OF c-MYC AND MLL GENES
AS A MARKER OF CLONAL CELL PROGRESSION
IN PATIENTS WITH MYELOID MALIGNANCY
AND TRISOMY OF CHROMOSOMES 8 OR 11
Angelova S1,*, Jordanova M2, Spassov B1, Shivarov V1, Simeonova M3,
Christov I4, Angelova P3, Alexandrova K5, Stoimenov A1, Nikolova V1,
Dimova I6, Ganeva P1, Tzvetkov N4, Hadjiev E5, Toshkov S1
*Corresponding Author: Svetlana Angelova, Biologist, Laboratory of Cytogenetics and Molecular Biology,
National Specialized Hospital for Active Therapy of Hematological Diseases, 6, «Plovdivsko pole», Sofia, 1756,
Bulgaria; Tel.: +35929701133; Fax : +35929701107; E-mail: sv_angelru@abv.bg
page: 17
|
|
REFERENCES
1. Albertson D G. Gene amplification in cancer. Trends
Genet. 2006; 22(8): 447-455.
2. Gajduskova P, Snijders AM, Kwek S, Roydasgupta R,
Fridlyand J, Tokuyasu T, Pinkel D, Albertson DG. Genome
position and gene amplification. Genome Biol.
2007; 8(6): R120.1-16.
3. Osthus RC, Karim B, Prescott JE, Smith BD, McDevitt
M, Huso DL, Dang CV. The Myc target gene JPO1/
CDCA7 is frequently overexpressed in human tumors
and has limited transforming activity in vivo. Cancer
Res. 2005; 65(13): 5620-5627.
4. Poppe B, Vandesompele J, Schoch C, Lindvall C,
Mrózek K, Bloomfield CD, Beverloo HB, Michaux L,
Dastugue N, Herens C, Yigit N, De Paepe A, Hagemeijer
A, Speleman F. Expression analyses identify MLL as
a prominent target of 11q23 amplification and support
an etiologic role for MLL gain of function in myeloid
malignancies. Blood. 2004; 103(1): 229-235.
5. Andersen MK, Christiansen DH, Pedersen-Bjergaard
J. Amplification or duplication of chromosome band
21q22 with multiple copies of the AML1 gene and mutation
of the TP53 gene in therapy-related MDS and
AML. Leukemia. 2005; 19(2): 197-200.
6. Mauvieux L, Helias C, Perrusson N, Lioure B, Sorel N,
Brizard F, Lessard M. ETV6 (TEL) gene amplification
in a myelodysplastic syndrome with excess of blasts.
Leukemia. 2004; 18(8): 1436-1438.
7. Rayeroux KC, Campbell LJ. Gene amplification in
myeloid leukemias elucidated by fluorescence in situ
hybridization. Cancer Genet Cytogenet. 2009; 193(1):
44-53
8. Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang
J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL,
Chen J, Rowley JD, Zeleznik-Le NJ. Regulation of mir-
196b by MLL and its overexpression by MLL fusions
contributes to immortalization. Blood. 2009; 113(14):
3314-3322.
9. Popescu NC, Zimonjic DB. Chromosome-mediated alterations
of the MYC gene in human cancer. J Cell Mol
Med. 2002; 6(2): 151-159.
10. Meyer N, Penn LZ. Reflecting on 25 years with MYC.
Nat Rev Cancer. 2008; 8(12): 976-990.
11. Farag SS, Archerd KJ, Mrozek K, Vardiman JW, Carroll
AJ, Pettenati MJ, Morre JO, Kolitz JE, Mayer RJ, Stone
RM, Larson RA, Bloomfield CD. Isolated trisomy of
chromosomes 8, 11, 13 and 21 is an adverse prognostic
factor in adults with de novo acute myeloid leukemia:
Results from Cancer and Leukemia Group B 8461. Int J
Oncol. 2002, 21(5): 1041-1051.
12. Grimwade D, Hills RK. Independent prognostic factors
for AML outcome. Hematology Am Soc Hematol Educ
Program. 2009; 385: 385-395.
13. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards
CG, Arthur DC, Pettenati MJ, Patil SR, Rao KW, Watson
MS, Koduru PRK, Moore JO, Stone RM, Mayer
RJ, Feldman EJ, Davey FR, Schiffer CA, Larson RA,
Bloomfield CD. Pretreatment cytogenetic abnormalities
are predictive of induction success, cumulative incidence
of relapse, and overall survival in adult patients
with de novo acute myeloid leukemia: results from
Cancer and Leukemia Group B (CALGB 8461). Blood.
2002; 100(13): 4325-4336.
14. Wolman SR, Gundacker H, Appelbaum FR, Slovak
ML. Impact of trisomy 8 (+8) on clinical presentation,
treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. Blood.
2002; 100(1): 29-35.
15. Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics
in acute leukemia. Blood Rev. 2004, 18(2): 115-136.
16. Malcovati L, Germing U, Kuendgen A, Della Porta
MG, Pascutto C, Invernizzi R, Giagounidis A, Hildebrandt
B, Bernasconi P, Knipp S, Strupp C, Lazzarino
M, Aul C, Cazzola M. Time-dependent prognostic scoring
system for predicting survival and leukemic evolution
in myelodysplastic syndromes. J Clin Oncol. 2007;
25(23): 3505-3510.
17. Rucker FG, Bullinger L, Schwaenen C, Lipka DB,
Wessendorf S, Fröhling S, Bentz M, Miller S, Scholl C,
Schlenk RF, Radlwimmer B, Kestler HA, Pollack JR,
Lichter P, Döhner K, Döhner H. Disclosure of candidate
genes in acute myeloid leukemia with complex karyotypes
using microarray-based molecular characterization.
J Clin Oncol. 2006; 24(24): 3887-3894.
18. Schoch C, Schnittger S, Bursch S, Gerstner D, Hochhaus
A, Berger U, Hehlmann R, Hiddemann W, Haferlach
T. Comparison of chromosome banding analysis,
interphase- and hypermetaphase-FISH, qualitative and
quantitative PCR for diagnosis and for follow-up in
chronic myeloid leukemia: a study on 350 cases. Leukemia.
2002; 16(1): 53-59.
19. International System for Human Cytogenetic Nomenclature
(2009). Shaffer LG, Slovak ML, Campbell LJ,
Eds. Basel: S. Karger, 2009.
20. Virtaneva K, Wright FA, Tanner SM, Yuan B, Lemon
WJ, Caligiuri MA, Bloomfield CD, de La Chapelle
A, Krahe R. Expression profiling reveals fundamental
biological differences in acute myeloid leukemia with
isolated trisomy 8 and normal cytogenetics. Proc Natl
Acad Sci USA. 2001; 98(3): 1124-1129.
21. Schoch C, Kohlmann A, Dugas M, Kern W, Hiddemann
W, Schnittger S, Haferlach T. Genomic gains and losses
influence expression levels of genes located within the
affected regions: a study on acute myeloid leukemias
with trisomy 8, 11, or 13, monosomy 7, or deletion 5q.
Leukemia. 2005; 19(7): 1224-1228.
22. Chen G, Zeng W, Miyazato A, Billings E, Maciejewski
JP, Kajigaya S, Sloand EM, Young NS. Distinctive
gene expression profiles of CD34 cells from patients
with myelodysplastic syndrome characterized by specific
chromosomal abnormalities Blood. 2004; 104(13):
4210-4218.
23. Luo H, Li Q, O’Neal J, Kreisel F, Le Beau MM, Tomasson
MH. c-Myc rapidly induces acute myeloid leukemia
in mice without evidence of lymphoma-associated antiapoptotic
mutations. Blood. 2005; 106(7): 2452-2461.
24. Jain AN, Chin K, Borresen-Dale A-L, Erikstein BK,
Lonning PE, Kaaresen R, Gray JW. Quantitative analysis
of chromosomal CGH in human breast tumors associates
copy number abnormalities with p53 status
and patient survival. Proc Natl Acad Sci USA. 2001;
98(14): 7952-7957.
25. Strout MP, Lorsbach RB, Shearer P, Sandlund JT, Raimondi
SC. Double minute chromosomes and c-MYC
amplification in a child with secondary myelodysplastic
syndrome after treatment for acute lymphoblastic leukemia.
Leukemia. 2000; 14(7): 1314-1315.
26. Jennings BA, Mills KI. C-MYC locus amplification and
the acquisition of trisomy 8 in the evolution of chronic
myeloid leukaemia. Leuk Res. 1998; 22(10): 899-903.
27. Slovak ML, Ho JP, Pettenati MJ, Khan A, Douer D, Lal
S, Traweek ST. Localization of amplified MYC gene
sequences of double minute chromosomes in acute
myelogenous leukemia. Genes Chromosomes Cancer.
1994; 9(1): 62-67.
28. Storlazzi CT, Fioretos T, Paulsson K, Strömbeck B,
Lassen C, Ahlgren T, Juliusson G, Mitelman F, Johansson
RM. Identification of a commonly amplified 4.4
Mb region with overexpression of C8FW, but not MYC
and MYC-containing double minutes in myeloid malignancies.
Hum Mol Genet. 2004; 13(14): 1479-1485.
29. Whitman SP, Liu S, Vukosavljevic T, Rush LJ, Yu L, Liu
C, Klisovic MI, Maharry K, Guimond M, Strout MP,
Becknell B, Dorrance A, Klisovic RB, Plass C, Bloomfield
CD. The MLL partial tandem duplication: evidence
for recessice gain-of-function in acute myeloid leukemia
identifies a novel patient subgroup for moleculartargeted
therapy. Blood. 2005; 106(1); 345-352.
30. Tyybäkinoja A, Saarinen-Pihkala U, Elonen E, Knuutila
S. Amplified, lost and fused genes in 11q23-25 amplicon
in acute myeloid leukemia, an array-CGH study.
Genes Chromosomes Cancer. 2006; 45(3): 258-264.
31. Michaux L, Wlodarska I, Stul M, Dierlamm J, Mugneret
F, Herens C, Beverloo B, Verhest A, Verellen-Dumoulin
C, Verhoef G, Selleslag D, Madoe V, Lecomte M, DeprijckB,
Ferrant A, Delannoy A, Marichal S, Duhem C, Dicato
M, Hagemeiher A. MLL Amplification in myeoloid
leukemias: a study of 14 cases with multiple copies of
11q23. Genes Chromosomes Cancer. 2000; 29(1): 40-47.
|
|
|
|
 |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
